Page last updated: 2024-10-25

clioquinol and Hormone-Dependent Neoplasms

clioquinol has been researched along with Hormone-Dependent Neoplasms in 1 studies

Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, D1
Cui, QC1
Yang, H1
Barrea, RA1
Sarkar, FH1
Sheng, S1
Yan, B1
Reddy, GP1
Dou, QP1

Other Studies

1 other study available for clioquinol and Hormone-Dependent Neoplasms

ArticleYear
Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts.
    Cancer research, 2007, Feb-15, Volume: 67, Issue:4

    Topics: Androgen Receptor Antagonists; Animals; Apoptosis; Cell Line, Tumor; Clioquinol; Copper; Humans; Mal

2007